All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-YC0308 | Anti-CRADD (CBYCD-132) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | CBYCD-132 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC1208 | Anti-CRADD (CBYCD-132) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | CBYCD-132 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ0618 | Anti-CRADD (CBXC-0551) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXC-0551 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ4042 | Anti-CRADD (CBXC-0551) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXC-0551 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY2960 | Anti-CRADD (CBFYC-2186) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYC-2186 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY2961 | Anti-CRADD (CBFYC-2187) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYC-2187 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY6213 | Anti-CRADD (CBFYC-2186) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYC-2186 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY6214 | Anti-CRADD (CBFYC-2187) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYC-2187 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ0571 | Anti-CRADD (CBWJC-3060) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBWJC-3060 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ2863 | Anti-CRADD (CBWJC-3060) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBWJC-3060 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION